ProCaLung - Peer review in stage III, mediastinal node-positive, non-small-cell lung cancer: How to benchmark clinical practice of nodal target volume definition and delineation in Belgium<sup>☆</sup>.
Auteurs : Charlier F, Descamps T, Lievens Y, Geets X, Remouchamps V, Lambrecht M, Moretti L Jaar : 2022 Journal : Radiother Oncol
Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry.
Auteurs : Jongen A, Charlier F, Baker K, Chang J, Hartsell W, Laramore G, Mohindra P, Moretti L, Redman M, Rosen L, Tsai H, Van Gestel D, Vargas C, Rengan R Jaar : 2022 Journal : Adv Radiat Oncol
Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.
Auteurs : Giunta EF, Bregni G, Pretta A, Deleporte A, Liberale G, Bali MA, Moretti L, Troiani T, Ciardiello F, Hendlisz A, Sclafani F Jaar : 2021 Journal : Cancer Treat Rev
Lung Cancer in Belgium.
Auteurs : Ocak S, Tournoy K, Berghmans T, Demedts I, Durieux R, Janssens A, Moretti L, Nackaerts K, Pieters T, Surmont V, Van Eycken L, Vrijens F, Weynand B, van Meerbeeck JP Jaar : 2021 Journal : J Thorac Oncol
Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question.
Auteurs : Van Houtte P, Moretti L, Charlier F, Roelandts M, Van Gestel D Jaar : 2021 Journal : Transl Lung Cancer Res